Reader Response: Ciphergen Responds to Lumicyte Story: ABI nixes Lite Brite | GenomeWeb

William Rich, CEO of Ciphergen, writes to BioArray News:

...The March 15 article “Lumicyte Battles Arch-Rival Ciphergen For Protein Profiling Biochip Dominance,” leaves readers with what I believe is a false impression — that because we sell our system in the research market, as well as perform services here, our ProteinChip technology has limited capability. Let me set the record straight.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.